Cabot Corporation (NYSE:CBT – Get Free Report) CEO Sean Keohane sold 91,923 shares of the stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the sale, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,921,218.94. The trade was a 18.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Cabot Stock Up 0.7%
Shares of Cabot stock traded up $0.58 on Tuesday, reaching $87.03. The stock had a trading volume of 428,298 shares, compared to its average volume of 483,177. The company has a 50 day moving average price of $87.91 and a 200 day moving average price of $80.05. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53. The stock has a market capitalization of $4.49 billion, a P/E ratio of 24.52, a P/E/G ratio of 11.45 and a beta of 0.84.
Cabot (NYSE:CBT – Get Free Report) last posted its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. Cabot’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities research analysts forecast that Cabot Corporation will post 6.32 EPS for the current year.
Cabot Dividend Announcement
Analysts Set New Price Targets
Several analysts have weighed in on the stock. Mizuho boosted their target price on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Truist Financial set a $100.00 price target on shares of Cabot in a report on Wednesday, August 5th. JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Finally, Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research note on Sunday. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot presently has a consensus rating of “Hold” and an average price target of $89.00.
Read Our Latest Research Report on Cabot
Institutional Trading of Cabot
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Torren Management LLC acquired a new position in shares of Cabot in the fourth quarter worth about $26,000. Rothschild Investment LLC increased its stake in shares of Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 259 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares in the last quarter. Global Retirement Partners LLC raised its holdings in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares during the period. Finally, Danske Bank A S acquired a new position in Cabot in the 3rd quarter worth about $38,000. Institutional investors and hedge funds own 93.18% of the company’s stock.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Featured Articles
- Five stocks we like better than Cabot
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
